LAUSR

The aim of this study is to investigate the regulatory mechanism of circPDSS1/miR‐186‐5p/NEK2 axis on the viability and proliferation in gastric cancer (GC) cell line. Differentially expressed circRNAs, miRNAs, and mRNAs in GC tissues and paracarcinoma tissues were analyzed using gene chips GSE83521, GSE89143, and GSE93415. Then, the expression of circPDSS1, miR‐186‐5p, and NEK2 was analyzed via quantitative real‐time polymerase chain reaction (qRT‐PCR). Survival analysis was adopted to explore the association between the circPDSS1 expression and the prognosis of GC. The effect of circPDSS1 on GC cell cycle and apoptosis was verified with the flow cytometry. Targeting relationships among circPDSS1, miR‐186‐5p, and NEK2 were predicted via bioinformatics analysis and demonstrated by the dual‐luciferase reporter assay. Our results showed that circPDSS1 and NEK2 were high‐expressed whereas miR‐186‐5p was low‐expressed in GC tissues and cells. CircPDSS1 promoted GC cell cycle and inhibited apoptosis by sponging miR‐186‐5p, while miR‐186‐5p inhibited cell cycle and promoted apoptosis by targeting NEK2. Thus, circPDSS1 acts as a tumor promoter by regulating miR‐186‐5p and NEK2, which could be a potential biomarker and therapeutic target for the management of GC.